Dossier Enxaqueca
Os critérios para o tratamento profiláctico da enxaqueca são23:
1. Enxaqueca recorrentes que na opinião do doente interfiram significativamente com as actividades diárias de rotina
2. Crises de enxaqueca frequentes (mais de duas por mês e que provoquem no total três ou mais dias de incapacidade). Mesmo doentes com menos de duas crises de enxaqueca por mês podem sofrer de incapacidade suficientemente grave que requeira tratamento profiláctico
3. Uso excessivo de terapêutica aguda para a enxaqueca (mais de duas vezes por semana)
4. Terapêutica aguda contra-indicada, ineficaz ou não tolerada
5. Preferência do doente
Referências:
1. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for
neurology. Arch Neurol. 2000;57:418-420.
2. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
3. Lipton RB. Diagnosis and epidemiology of pediatric migraine. Curr Opin Neurol. 1997;10:231-236.
4. Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache. 1985;25:376-379.
5. Dahlof CGH, Dimenas E. Migraine patients experience poorer subjective wellbeing/ quality of life even between attacks. Cephalalgia. 1995;15:31-36.
6. Hu HX, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159:813-818.
7. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF: Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638-645.
8. Russel MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ. 1995;311:541-544.
9. Joutel A, Bousser MG, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40-45.
10. May A, Ophoff RA, Terwindt GM, et al. Familial hemiplegic migraine locus on 19p13 is involved in the com-monforms of migraine with and without aura. Hum Genet. 1995;96:604-608.
11. Terwindt GM, Ophoff RA, van Eijk R, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with or without aura. Neurology. 2001;56:1028- 1032.
12. Tottene A, Fellin T, Pagnutti S, et al. Familial hemiplegic migraine mutations increase Ca82+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc Natl Acad Sci U S A. 2002;99:13284-13289.
13. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003;4:386-398.
14. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache. 1995;35:387-396.
15. Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In: Wolff’s Headache and Other Head Pain. 7th ed. New York: Oxford University Press; 2001:121-237.
16. Silberstein SD, Lipton RB, Goadsby PJ. Migraine: diagnosis and treatment. In: Headache in Clinical Practice. 2nd ed. London, UK: Martin Dunitz; 2002:69-111.
17. Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry. 1960;23:23-32.
18. Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch Intern Med. 1992;156:1273-1278.
19. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol. 1995;15:175- 182.
20.Matchar DB, Young WB, Rosenberg JH, et al. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management of acute attacks. Available at: http://www.aan.com/professionals/practice/pdfs/gl0087.pdf
20. Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical Practice. 2nd ed. Oxford, UK: Martins Dunitz; 2002.
21. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Avalable at: http://www.aan.com/professionals/practice/pdfs/gl0090.pdf (Accessed June 4, 2003)
22. Snow V, et al., for the American Academy of Family Physicians and the College of Physicians – American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headaches. Ann Intern Med. 2002;137:840-849.
